Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$200M |
| 2 |
Danaher
DHR
|
+$146M |
| 3 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$138M |
| 4 |
Procter & Gamble
PG
|
+$122M |
| 5 |
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
|
+$109M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.89B |
| 2 |
Microsoft
MSFT
|
+$380M |
| 3 |
Alibaba
BABA
|
+$352M |
| 4 |
Wells Fargo
WFC
|
+$245M |
| 5 |
American Electric Power
AEP
|
+$243M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 11.91% |
| 2 | Technology | 7.43% |
| 3 | Financials | 6.52% |
| 4 | Consumer Discretionary | 5.69% |
| 5 | Industrials | 4.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
Wynn Resorts
WYNN
$10.3B
| $13.5M | 0.03% |
224,542
-7,341
| -3% | -$822K |
|
652
Douglas Emmett
DEI
$1.97B
| $13.5M | 0.03% |
441,852
-1,613,626
| -79% | -$62.8M |
|
653
Halliburton
HAL
$29.4B
| $13.4M | 0.03% |
1,960,970
-141,774
| -7% | -$2.47M |
|
654
Performance Food Group
PFGC
$16.5B
| $13.4M | 0.03% |
543,135
-599,749
| -52% | -$25.8M |
|
|
CLGX
655
DELISTED
Corelogic, Inc.
CLGX
| $13.4M | 0.03% |
437,729
+344,572
| +370% | +$15.3M |
|
|
STOR
656
DELISTED
STORE Capital Corporation
STOR
| $13.3M | 0.03% |
736,566
+727,482
| +8,008% | +$24M |
|
657
CALL
Altria Group
MO
$110B
| $13.3M | 0.03% |
344,800
+333,100
| +2,847% | +$14.8M |
|
658
Healthcare Realty
HR
$6.65B
| $13.3M | 0.03% |
548,801
-827,207
| -60% | -$25M |
|
659
Reinsurance Group of America
RGA
$15.9B
| $13.3M | 0.03% |
158,317
+38,533
| +32% | +$5.02M |
|
660
Factset
FDS
$10.7B
| $13.3M | 0.03% |
51,099
-4,958
| -9% | -$1.35M |
|
|
PACW
661
DELISTED
PacWest Bancorp
PACW
| $13.3M | 0.03% |
740,580
+252,297
| +52% | +$7.91M |
|
|
662
CALL
Wells Fargo
WFC
$254B
| $13.2M | 0.03% |
460,100
+189,800
| +70% | +$8.07M |
|
663
CALL
Edwards Lifesciences
EW
$51.8B
| $13.2M | 0.03% |
210,000
+179,100
| +580% | +$12.9M |
|
664
Box
BOX
$4.56B
| $13.2M | 0.03% |
940,165
-858,188
| -48% | -$12.8M |
|
665
MetLife
MET
$60B
| $13.2M | 0.03% |
431,666
-2,830,812
| -87% | -$126M |
|
|
HES
666
DELISTED
Hess
HES
| $13.2M | 0.03% |
395,893
+348,367
| +733% | +$18.8M |
|
|
CNST
667
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $13.1M | 0.03% |
415,968
-152,831
| -27% | -$5.31M |
|
668
Cable One
CABO
$129M
| $13.1M | 0.03% |
7,947
+6,343
| +395% | +$10.1M |
|
669
PUT
Newmont
NEM
$139B
| $13M | 0.03% |
288,000
-617,400
| -68% | -$27.9M |
|
670
XPO
XPO
$23.2B
| $13M | 0.03% |
772,048
+749,596
| +3,339% | +$20M |
|
671
Acadia Pharmaceuticals
ACAD
$5.08B
| $13M | 0.03% |
307,846
-680,467
| -69% | -$28M |
|
672
American Express
AXP
$227B
| $13M | 0.03% |
151,341
-574,885
| -79% | -$66.9M |
|
|
CETV
673
DELISTED
Central European Media Enterprises Ltd
CETV
| $12.9M | 0.03% |
4,133,545
+2,583,132
| +167% | +$10.5M |
|
674
Equifax
EFX
$22.6B
| $12.9M | 0.03% |
108,070
+98,886
| +1,077% | +$14.4M |
|
675
BioCryst Pharmaceuticals
BCRX
$2.44B
| $12.9M | 0.03% |
6,452,341
-3,488,336
| -35% | -$9.6M |
|
Similar funds
Israel Englander's Q1 2020 Portfolio in Review
As of Q1 2020, Israel Englander held 4,928 positions worth $44.5B, down 44% from $79.9B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Israel Englander withdrew a net $21.4B in Q1 2020, closing 1,154 positions and reducing 1,745 holdings. Its most notable exit was Becton Dickinson, an estimated $152M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 10% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Danaher worth $133M.
- Israel Englander's largest Q1 2020 buy was Danaher: 1,082,448 shares worth $133M.
- Israel Englander added most to Allergan plc in Q1 2020, an estimated $200M increase.
- Israel Englander's biggest Q1 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $3.89B.
- Israel Englander fully exited Becton Dickinson in Q1 2020, selling an estimated $152M.
- Israel Englander's ten largest holdings make up 18% of its $44.5B portfolio in Q1 2020.
- Israel Englander opened 789 new positions and closed 1,154 in Q1 2020.
- Israel Englander's portfolio value fell 44% quarter-over-quarter to $44.5B.
Based on Millennium Management's 13F filing for Q1 2020, filed 14 May 2020.